"Východoslovenský onkologický ústav Košice vznikol 1.7.2003 a dňa 20.2.2006 sa transformoval na akciovú spoločnosť s názvom Východoslovenský onkologický ústav, a.s.. Jeho poslaním je predovšetkým poskytovať komplexnú ambulantnú a ústavnú zdravotnú starostlivosť pacientom s onkologickým ochorením – diagnostika, liečba a dispenzárna starostlivosť o onkologických pacientov. V ústavnej starostlivosti zabezpečuje onkologickú, onko-otorinolaryngologickú, onko-gynekologickú starostlivosť, komplexnú protinádorovú liečbu – radiačnú a chemoterapeutickú liečbu. Okrem iného zabezpečuje teoretickú i praktickú časť výučby žiakov stredných zdravotníckych škôl, teoretickú i praktickú časť vysokoškolského vzdelávania v zdravotníckych povolaniach."

During the past decade, Vychodoslovensky onkologicky ustav, a.s. conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 9 clinical trials were completed, i.e. on average, 64.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vychodoslovensky onkologicky ustav, a.s." #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Pfizer" with 7 trials sponsored, "Arcus Biosciences, Inc." with 1 trials sponsored, "Ferring Pharmaceuticals" with 1 trials sponsored and "Janssen Pharmaceutica N.V., Belgium" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vychodoslovensky onkologicky ustav, a.s." #1 collaborator was "Astellas Pharma Inc" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator and "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Vychodoslovensky onkologicky ustav, a.s." are "Prostate Cancer" (4 trials), "Cancer of the Prostate" (2 trials), "Early Breast Cancer" (2 trials), "NSCLC" (2 trials) and "Neoplasms" (2 trials). Many other conditions were trialed in "Vychodoslovensky onkologicky ustav, a.s." in a lesser frequency.

Most popular intervention types in "Vychodoslovensky onkologicky ustav, a.s." are "Drug" (18 trials), "Biological" (2 trials), "Dietary Supplement" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (3 trials), "Docetaxel" (3 trials), "Pemetrexed" (3 trials), "Cetuximab" (2 trials) and "Encorafenib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Vychodoslovensky onkologicky ustav, a.s." are 11 trials for "All" genders, 5 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Vychodoslovensky onkologicky ustav, a.s.". undefined are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Vychodoslovensky onkologicky ustav, a.s., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Vychodoslovensky onkologicky ustav, a.s., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".

Vychodoslovensky onkologicky ustav, a.s. has several departments that took part in Clinical trials: "Vychodoslovensky onkologicky ustav Oddelenie klinickej onkologie" - 2 trials